Search research articles
Contact Us
Filters
Showing results (71-80 of 312) with videos related to
Page
of 32
Sort By:
Anti-Cancer Drugs
|
January 30, 2010
Breast cancer: complete response with the combination of sunitinib and trastuzumab in a patient with grade III ductal carcinoma
Javier Puente, Aranzazu Manzano, Miguel Martin, et al.
Cadernos De Saude Publica
|
April 10, 2014
Sylvatic rabies and the perception of vampire bat activity in communities in the Ecuadorian Amazon
Natalia Romero-Sandoval, Natalia Escobar, Mireia Utzet, et al.
Frontiers in Endocrinology
|
June 13, 2020
Purinergic Signaling During Hyperglycemia in Vascular Smooth Muscle Cells
Miguel Martin-Aragon Baudel, Ricardo Espinosa-Tanguma, Madeline Nieves-Cintron, et al.
Applied Biosafety : Journal of the American Biological Safety Association
|
February 10, 2023
A Mentorship Program to Develop Biorisk Manuals for Laboratories in Pakistan
Samreen Sarwar, Miguel Martin N Moreno, Mashaal Chaudhri, et al.
Future Oncology (London, England)
|
January 31, 2022
How we treat HR-positive, HER2-negative early breast cancer
Sara Lopez-Tarruella, Isabel Echavarria, Yolanda Jerez, et al.
Microcirculation (New York, N.Y. : 1994)
|
August 27, 2024
Vascular Function and Ion Channels in Alzheimer's Disease
Jade L Taylor, Miguel Martin-Aragon Baudel, Madeline Nieves-Cintron, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 25, 2021
Reply to K. Hashimoto and A. Shimomura
Stephen R D Johnston, Nadia Harbeck, Masakazu Toi, et al.
BMC Pediatrics
|
September 19, 2020
Pulse oximetry curves in healthy children living at moderate altitude: a cross-sectional study from the Ecuadorian Andes
Vinicio Andrade, Felipe Andrade, Pablo Riofrio, et al.
Clinical Breast Cancer
|
November 26, 2009
TRIO-012: a multicenter, multinational, randomized, double-blind phase III study of IMC-1121B plus docetaxel versus placebo plus docetaxel in previously untreated patients with HER2-negative, unresectable, locally recurrent or metastatic breast cancer
John Mackey, Karen Gelmon, Miguel Martin, et al.
Ecology and Evolution
|
November 7, 2022
The potential of Jellytoring 2.0 smart tool as a global jellyfish monitoring platform
Ana Ruiz-Frau, Miguel Martin-Abadal, Charlotte L Jennings, et al.
Page
of 32
Search research articles
Search
Showing results (71-80 of 312) with videos related to
Sort By:
Page
of 32
Anti-Cancer Drugs
|
January 30, 2010
Breast cancer: complete response with the combination of sunitinib and trastuzumab in a patient with grade III ductal carcinoma
Javier Puente, Aranzazu Manzano, Miguel Martin, et al.
Cadernos De Saude Publica
|
April 10, 2014
Sylvatic rabies and the perception of vampire bat activity in communities in the Ecuadorian Amazon
Natalia Romero-Sandoval, Natalia Escobar, Mireia Utzet, et al.
Frontiers in Endocrinology
|
June 13, 2020
Purinergic Signaling During Hyperglycemia in Vascular Smooth Muscle Cells
Miguel Martin-Aragon Baudel, Ricardo Espinosa-Tanguma, Madeline Nieves-Cintron, et al.
Applied Biosafety : Journal of the American Biological Safety Association
|
February 10, 2023
A Mentorship Program to Develop Biorisk Manuals for Laboratories in Pakistan
Samreen Sarwar, Miguel Martin N Moreno, Mashaal Chaudhri, et al.
Future Oncology (London, England)
|
January 31, 2022
How we treat HR-positive, HER2-negative early breast cancer
Sara Lopez-Tarruella, Isabel Echavarria, Yolanda Jerez, et al.
Microcirculation (New York, N.Y. : 1994)
|
August 27, 2024
Vascular Function and Ion Channels in Alzheimer's Disease
Jade L Taylor, Miguel Martin-Aragon Baudel, Madeline Nieves-Cintron, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 25, 2021
Reply to K. Hashimoto and A. Shimomura
Stephen R D Johnston, Nadia Harbeck, Masakazu Toi, et al.
BMC Pediatrics
|
September 19, 2020
Pulse oximetry curves in healthy children living at moderate altitude: a cross-sectional study from the Ecuadorian Andes
Vinicio Andrade, Felipe Andrade, Pablo Riofrio, et al.
Clinical Breast Cancer
|
November 26, 2009
TRIO-012: a multicenter, multinational, randomized, double-blind phase III study of IMC-1121B plus docetaxel versus placebo plus docetaxel in previously untreated patients with HER2-negative, unresectable, locally recurrent or metastatic breast cancer
John Mackey, Karen Gelmon, Miguel Martin, et al.
Ecology and Evolution
|
November 7, 2022
The potential of Jellytoring 2.0 smart tool as a global jellyfish monitoring platform
Ana Ruiz-Frau, Miguel Martin-Abadal, Charlotte L Jennings, et al.
Page
of 32